Rapid Risk Assessment: Cluster of pneumonia cases caused by a novel coronavirus, Wuhan, China, 2020
A novel coronavirus (2019-nCoV) has been isolated and considered the causative agent of the cluster of 41 pneumonia cases in the area of Wuhan, Hubei province in China, as well as of the three travel-related cases in Thailand and Japan, arriving from Wuhan.
Pneumonia cases possibly associated with a novel coronavirus in Wuhan, China
Between 31 December and 5 January, 59 pneumonia cases possibly associated with a novel coronavirus have been reported in Wuhan, China with a common exposure link to Wuhan’s South China Seafood City market.
Rapid risk assessment: Outbreak of carbapenemase-producing Enterobacterales in Lithuania, 2019
Between 1st February and 26th November 2019, 199 cases of Klebsiella pneumoniae carbapenemase (KPC)-producing carbapenem-resistant Enterobacterales (KPC-CRE) have been detected in Lithuania.
Rapid risk assessment: Cases of Lassa fever in the Netherlands ex Sierra Leone
On 20 and 24 November 2019, respectively, the Dutch public health authorities confirmed two imported cases of Lassa fever from Sierra Leone. Both were Dutch healthcare workers who worked in a rural hospital in Sierra Leone.
Rapid outbreak assessment: Multi-country outbreak of Listeria monocytogenes sequence type 6 infections linked to ready-to-eat meat products
Twenty-one cases of Listeria monocytogenes IVb sequence type ST 6 infections have been reported from the Netherlands (19 cases) and Belgium (two cases). This outbreak was identified using whole genome sequencing (WGS) analysis.
Rapid risk assessment - Sexual transmission of dengue in Spain
Spanish authorities have reported the likely sexual transmission of dengue between two men. One of the men travelled to Cuba and the Dominican Republic (both countries where dengue is endemic) and returned to Spain on 4 September 2019.
Outbreak of carbapenemase-producing (NDM-1 and OXA-48) and colistin-resistant Klebsiella pneumoniae ST307, north-east Germany, 2019
Germany has reported an outbreak of carbapenemase-producing (NDM-1 and OXA-48) and colistin-resistant Klebsiella pneumoniae sequence type (ST) 307. As of 21 October 2019, 17 patients in three hospitals and one rehabilitation clinic in Mecklenburg-West Pomerania in north-east Germany have been affected. Six of the 17 cases presented with clinical symptoms of infection, while 11 were identified as be carriers.
Rapid risk assessment: Zika virus disease in Var department, France
On 1 October 2019, a case of locally acquired Zika virus (ZIKV) disease in France (Hyères city, Var department) was laboratory confirmed. To date, and based on ECDC’s epidemiological assessment, the probability of ongoing vector-borne local transmission in Hyères (and surrounding areas) is considered very low because current evidence does not indicate the existence of a more extensive cluster of ZIKV cases.
Rapid risk assessment: Autochthonous cases of dengue in Spain and France
Three autochthonous cases of dengue have been reported in France and Spain. The probability of further local sustained transmission remains very low, both in Spain and in France. Environmental conditions will become progressively less suitable for transmission over the autumn season.
Carbapenem resistant Enterobacteriaceae - second update
Carbapenem resistance in Enterobacteriaceae such as Klebsiella pneumoniae and Escherichia coli poses a significant threat to patients and healthcare systems in all European Union/European Economic Area (EU/EEA) countries. Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high mortality, primarily due to delays in administration of effective treatment and the limited availability of treatment options. Hypervirulent carbapenem-resistant K. pneumoniae strains have been reported presenting an additional threat with a potential for global dissemination. The spread of high risk clones and plasmids carrying carbapenemases in healthcare settings is a major cause of the spread of CRE in EU/EEA countries. Recent events of cross-border importation after patient transfer and large regional outbreaks as well as the worsening epidemiologic situation of carbapenemase-producing CRE in the EU/EEA highlight the high risk for further spread of CRE and the need for enhanced control efforts. Options for control are outlined in the respective section below.